title: A double-blind, multicenter clinical trial comparing efficacy of once-daily metronidazole 1 percent cream to vehicle in patients with rosacea.
abstract: The efficacy and safety of a new formulation of metronidazole 1 percent cream applied once daily was compared to vehicle cream in a double-blind, randomized, parallel group, ten-week clinical study. The results showed that metronidazole 1 percent cream was significantly better than vehicle in reducing the lesions of rosacea, improving erythema, and physician's global rosacea scores. The incidence of adverse events related to the skin was low.
authors.affiliation: Dermik Laboratories, Inc., Collegeville, Pennsylvania 19426-1200, USA.
authors.forename: D L
authors.initials: DL
authors.lastname: Breneman
authors.forename: D
authors.initials: D
authors.lastname: Stewart
authors.forename: O
authors.initials: O
authors.lastname: Hevia
authors.forename: P D
authors.initials: PD
authors.lastname: Hino
authors.forename: L A
authors.initials: LA
authors.lastname: Drake
mesh_terms: D000287:Administration, Topical; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008795:Metronidazole / Q000008:administration & dosage / Q000627:therapeutic use*; D008875:Middle Aged; D012393:Rosacea / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D000893:Anti-Inflammatory Agents; D008795:Metronidazole